Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Allergen immunotherapy (9)
  • Asthma (4)
  • Basic immunology (3)
  • x Biologicals (2)
  • ENT (2)
  • Eosinophilic esophagitis (1)
  • x Epidemiology (1)
  • Ocular allergy (1)
  • Pediatrics (1)
Poster available until
Poster categories
  • Thematic Poster Session (3)
keywords
Session Reference
  • L-TPS02 (9)
  • L-TPS03 (1)
  • L-TPS07 (11)
  • L-TPS08 (2)
  • L-TPS09 (3)
  • L-TPS10 (4)
  • L-TPS13 (1)
  • L-TPS14 (1)
  • L-TPS19 (1)
  • L-TPS20 (1)
  • L-TPS21 (1)
  • TPS01 (5)
  • TPS02 (1)
  • TPS05 (1)
  • TPS06 (8)
  • x TPS09 (3)
  • TPS10 (4)
  • TPS14 (1)
  • TPS16 (1)
  • TPS17 (4)
  • TPS18 (9)
  • TPS21 (1)
  • TPS28 (5)
  • TPS29 (1)
  • TPS31 (2)
  • TPS34 (2)
  • TPS37 (9)
  • TPS38 (1)
  • TPS44 (2)
  • TPS46 (5)
  • TPS51 (2)
  • TPS52 (5)
  • TPS54 (2)
  • TPS55 (10)
  • TPS56 (5)
  • TPS57 (6)
  • TPS63 (1)
  • TPS67 (9)
  • TPS68 (2)
  • TPS69 (2)
3 results
Thumbnail

D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units

Thumbnail

D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Thumbnail

D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM